netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

RPB AWARDS $5.4 MILLION IN GRANTS

Research to Prevent Blindness (RPB) awarded 27 grants totaling $5.4 million during its Fall 2016 grant cycle. The latest awards include unrestricted grants to departments of ophthalmology at 17 medical schools across the United States and 10 awards to individual scientists.

RPB currently funds research at 40 medical institutions throughout the U.S., where RPB-supported laboratories investigate the entire spectrum of eye disease, from cataracts, glaucoma, and diabetic retinopathy to macular degeneration, retinitis pigmentosa and eye movement disorders.

Among the newly funded investigations are: the development of animal models of diabetic eye disease to learn how fenofibrate, a drug clinically-approved to treat cholesterol, protects the eye from diabetes-related damage; the development of a specialized camera to capture how the retina's rods and cones (responsible for turning light energy into shapes and colors) work in health and how they fail in retinal diseases; and the exploration of mechanisms by which intestinal tract bacteria impact the health of the eye.

The first Research to Prevent Blindness/Starvos Niarchos Foundation International Research Collaborators Award was awarded to Adam Kohn, PhD, of Albert Einstein College of Medicine in New York City, and his international collaborator, Samuel Solomon, PhD, of University College London. The new Award promotes international collaborations through which researchers in the U.S. and outside the U.S. gain knowledge and skills and enhance each other's work. Drs. Kohn and Solomon seek to examine how feedback signals change the activity of nerve cells in the visual cortex, and thereby influence our capacity to see. 

Since it was founded in 1960, RPB has channeled more than $346 million into eye research.  As a result, RPB has been identified with nearly every major breakthrough in vision research in that time. Learn more about our current and past grantees here.

Related News: Feature Story, Top Story

RPB-SUPPORTED RESEARCHERS WILL BE INTEGRAL PART OF LATEST EFFORT WITHIN NEI’S AUDACIOUS GOALS INITIATIVE

Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.

Read More

 

EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS

(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.

Read More

 

RESEARCH TO PREVENT BLINDNESS AND LIONS CLUBS INTERNATIONAL FOUNDATION TO CONTINUE LOW VISION RESEARCH AWARD PARTNERSHIP

Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.

Read More

 

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More

 

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Read More

 

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.